• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, October 3, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Scientists prevent “exhaustion” in cancer-fighting T cells

Bioengineer by Bioengineer
June 28, 2022
in Health
Reading Time: 5 mins read
0
Ansu Satpathy at Gladstone Institutes
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

SAN FRANCISCO, CA—When faced with a formidable foe for months on end, the immune system’s T cells begin to tire. Whether fighting a cancer or a chronic infection, they become less effective over time, a phenomenon dubbed “T cell exhaustion” by scientists. Now, researchers at Gladstone Institutes and Stanford University have revealed the genetic switches that get flipped in exhausted T cells. In the process, they discovered how to prevent this immune exhaustion—a major step toward improving immune-based treatments for cancer.

Ansu Satpathy at Gladstone Institutes

Credit: Photo: Michael Short/Gladstone Institutes

SAN FRANCISCO, CA—When faced with a formidable foe for months on end, the immune system’s T cells begin to tire. Whether fighting a cancer or a chronic infection, they become less effective over time, a phenomenon dubbed “T cell exhaustion” by scientists. Now, researchers at Gladstone Institutes and Stanford University have revealed the genetic switches that get flipped in exhausted T cells. In the process, they discovered how to prevent this immune exhaustion—a major step toward improving immune-based treatments for cancer.

“The exciting thing about these results is that they give us potential paths forward for boosting the ability of T cells to maintain a long-term fight against cancer cells,” says Alex Marson, MD, PhD, director of the Gladstone-UCSF Institute of Genomic Immunology and an author of the new study published in Cancer Cell.

“Cancer immunotherapies have been transformative for a portion of cancer patients; but the reality is that in a majority, they don’t currently work, often because of T cell exhaustion,” says Ansuman Satpathy, MD, PhD, an assistant professor in the Department of Pathology at the Stanford School of Medicine and a core member of the Gladstone-UCSF Institute of Genomic Immunology, who led the study. “Our work has the potential to change that.”

What Makes T Cells Tire?

The T cells found in the human immune system are some of the front-line soldiers in recognizing, attacking, and directing the fight against foreign cells and molecules. They recognize their opponents—from pathogens to cancers—through unique receptors on their surfaces. When a molecule binds to one of these T cell receptors, it activates the T cell, which begins producing a variety of immune molecules. Scientists have long known, however, that this response diminishes over time. When a T cell receptor is activated continuously for weeks or months, the cell gradually produces fewer immune molecules and becomes less effective at destroying a cancer or pathogen.

In the new study, Satpathy and his collaborators—including Julia Carnevale, MD, a physician-scientist at UC San Francisco (UCSF) and a core member of the Gladstone-UCSF Institute of Genomic Immunology; Santosh Vardhana, MD, PhD, a medical oncologist at Memorial Sloan Kettering Cancer Center; and Crystal Mackall, MD, a professor of pediatrics and of medicine at the Stanford School of Medicine—set out to better characterize what occurs during this shift.

Stanford graduate student Julia Belk, the first author of the new paper, developed a model of T cell exhaustion that could be used to study isolated immune cells in a dish. She showed that constantly activating the receptors of isolated T cells was a good mimic of what occurred in the vicinity of human cancers.

Then, the team used CRISPR-Cas9 gene editing to alter tens of thousands of genes—one at a time—in the cells. They tested which T cells showed more or less exhaustion than usual after constant activation of their T cell receptors. This let the researchers identify which genes were most important in triggering T cell exhaustion.

“This is the first genome-wide screen for the genes that are involved in T cell exhaustion,” says Belk. “A typical approach would be to study one or two genes at a time, but our strategy enabled us to systematically test every gene in the genome at once.”

Pinpointing Master Switches

Researchers long thought that T cell exhaustion might be driven by just a few genes that ended up permanently switched on or off after chronic receptor activation. But in recent years, studies on exhausted T cells began to hint that the cells undergo more major rewiring, with thousands of genes turned on or off.

The genes that Satpathy’s group found to be linked to T cell exhaustion helped support this idea; the most critical genes were epigenetic regulators, which remodel the physical structure of DNA to turn on or off hundreds of genes at once. These findings help explain how completely different an exhausted T cell is from other functional T cell states.

The researchers carried out detailed analyses of the epigenetic regulators identified in their screen to understand how they interacted with each other, and homed in on a few particularly important genes. Then, they used CRISPR/Cas9 gene editing to further study the effects of blocking individual genes in T cells that were delivered into living mice.

They showed that in mice with tumors, blocking the gene Arid1a led to higher levels of T cells and smaller tumors after just 15 days. Moreover, at a molecular level, the T cells from those mice more closely resembled healthy, persistent immune cells than exhausted, less active T cells.

A Path Toward Therapeutics

The researchers say that more work is needed to better understand the effect of altering epigenetic factors like Arid1a in humans with cancer. But their results indicate that altering these genes—or some of the genes that they control—might improve the effectiveness of existing immunotherapies.

“This study gives us multiple different shots on goal to try to help T cells avoid exhaustion and therefore improve immunotherapies,” says Marson.

The findings also could inform the development of treatments to help the immune system ward off chronic viral infections, he adds.

###

About the Research Project

The paper “Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistence” was published in the journal Cancer Cell on June 23, 2022.

Other authors include Eric Shifrut of Gladstone; Winnie Yao, Nghi Ly, Katherine A. Freitas, Quanming Shi, Alfredo M. Valencia, Kathryn E. Yost, Connor V. Duffy, Bence Daniel, and Zhuang Miao of Stanford; Yan-Ting Chen and Madeline A. Hwee of Memorial Sloan Kettering Cancer Center; and Nupura Kale and Alan Ashworth of UCSF.

The work was supported by the National Institutes of Health (U01CA260852), the Burroughs Wellcome Fund, the Parker Institute for Cancer Immunotherapy, a Pew-Stewart Scholars for Cancer Research Award, the Cancer Research Institute, the Baxter Foundation, the Stanford Innovative Medicine Accelerator and Stanford ChEM-H, the Innovative Genomics Institute, a Stanford Graduate Fellowship, a National Science Foundation Graduate Research Fellowship (DGE-1656518), and a Mentored Clinical Scientist Career Development Award from the National Cancer Institute (K08 CA237731).

About Gladstone Institutes

To ensure our work does the greatest good, Gladstone Institutes focuses on conditions with profound medical, economic, and social impact—unsolved diseases. Gladstone is an independent, nonprofit life science research organization that uses visionary science and technology to overcome disease. It has an academic affiliation with the University of California, San Francisco.



Journal

Cancer Cell

DOI

10.1016/j.ccell.2022.06.001

Article Title

Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistence

Article Publication Date

23-Jun-2022

Share12Tweet8Share2ShareShareShare2

Related Posts

From Parkinson’s to Rare Diseases: Scientists Discover a Key Cellular Health Switch

October 3, 2025

SMFM Releases Updated Guidelines for Diagnosing and Managing Heart Failure in Pregnancy and Postpartum

October 3, 2025

New Study Reveals One-Year CT Scan Changes Predict Future Outcomes in Fibrotic Lung Disease

October 3, 2025

Assessing Infection Risk via Stochastic Microexposure Models

October 3, 2025

POPULAR NEWS

  • New Study Reveals the Science Behind Exercise and Weight Loss

    New Study Reveals the Science Behind Exercise and Weight Loss

    93 shares
    Share 37 Tweet 23
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    88 shares
    Share 35 Tweet 22
  • Physicists Develop Visible Time Crystal for the First Time

    75 shares
    Share 30 Tweet 19
  • New Insights Suggest ALS May Be an Autoimmune Disease

    66 shares
    Share 26 Tweet 17

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

From Parkinson’s to Rare Diseases: Scientists Discover a Key Cellular Health Switch

SMFM Releases Updated Guidelines for Diagnosing and Managing Heart Failure in Pregnancy and Postpartum

Scientists Uncover New Intracellular Trafficking Pathway in Plant Cells

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 62 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.